Achaogen Inc. hired Genentech Inc. veteran Dr. Kenneth Hillan as its chief medical officer, charged with advancing the South San Francisco biotech company’s antibiotic discovery and development programs.
Hillan, who spent 16 years in Genentech drug development, is the second Genenexer nabbed by privately held Achaogen since Swiss drug maker Roche bought South San Francisco-based Genentech two years ago. Achaogen last year hired former Genentech vice president of finance and corporate planning John Doyle as chief operating officer.
No comments:
Post a Comment